NCT04727229View on ClinicalTrials.gov

Stellate Ganglion Block for Major Depressive Disorder.

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

February 10, 2022

Study Completion Date

March 10, 2022

Conditions
Treatment Resistant DepressionMajor Depressive Disorder
Interventions
DRUG

Bupivacaine Hydrochloride

Injection of Bupivacaine near the stellate ganglion

DRUG

Normal Saline

Injection of Normal Saline near the stellate ganglion

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT04727229 - Stellate Ganglion Block for Major Depressive Disorder. | Biotech Hunter | Biotech Hunter